These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2813758)

  • 1. [On the contribution by B. Kimmig: "Radioiodine therapy and percutaneous radiotherapy of struma maligna"].
    Böttger I; Schober O
    Radiologe; 1989 Oct; 29(10):533-5. PubMed ID: 2813758
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioiodine therapy and percutaneous radiotherapy of struma maligna].
    Kimmig B
    Radiologe; 1989 Mar; 29(3):125-31. PubMed ID: 2652184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy of struma maligna].
    Engelken G; Hymmen U; Schenck P; Wieland C
    Chirurg; 1976 Aug; 47(8):435-8. PubMed ID: 821730
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved planning of radioiodine therapy for thyroid cancer.
    Medvedec M
    J Nucl Med; 2002 May; 43(5):714; author reply 714. PubMed ID: 11994536
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
    Dietlein M; Dressler J; Farahati J; Leisner B; Moser E; Reiners C; Schicha H; Schober O
    Nuklearmedizin; 1999; 38(6A):221-2. PubMed ID: 10510812
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radioiodine therapy of toxic adenomas of the thyroid gland].
    Kinser J; Rösler H
    Ther Umsch; 1973 Oct; 30(10):726-33. PubMed ID: 4745946
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
    Bestagno M; Campagnari G
    Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
    [No Abstract]   [Full Text] [Related]  

  • 8. Depletion regimens for radioiodine therapy of thyroid carcinoma.
    Jackson G
    J Nucl Med; 1985 Aug; 26(8):962. PubMed ID: 4032040
    [No Abstract]   [Full Text] [Related]  

  • 9. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 10. [Percutaneous radiotherapy of thyroid malignancies. Analysis of 54 cases].
    Hohenberg G; Heckenthaler W
    Wien Klin Wochenschr; 1982 Mar; 94(6):153-7. PubMed ID: 7101951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioiodine therapy a successful tool in treating thyroid cancer. Foreword.
    Bombardieri E; Pacini F
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):439. PubMed ID: 20205316
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.
    Hadjieva T
    Radiobiol Radiother (Berl); 1985; 26(6):819-23. PubMed ID: 4095270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
    Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
    Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroglobulin before ablative radioiodine therapy.
    Grünwald F; Menzel C; Biersack HJ
    Eur J Nucl Med; 2000 Apr; 27(4):461. PubMed ID: 10805121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Approximation errors in the physical planning of radioiodine therapy of the thyroid].
    Bogner L; Czempiel H
    Nuklearmedizin; 1993 Oct; 32(5):236-46. PubMed ID: 8233844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival times of patients with thyroid cancer following radioiodine therapy].
    Correns HJ; Buchali K; Donat R; zur Horst-Meyer H; Mitterlechner E
    Radiobiol Radiother (Berl); 1984; 25(3):405-10. PubMed ID: 6473745
    [No Abstract]   [Full Text] [Related]  

  • 19. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
    de Vathaire F
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of thyroid carcinoma using radioiodine].
    Santora J; Nĕmec J; Kubinyi J
    Cas Lek Cesk; 2001 Apr; 140(7):217-9. PubMed ID: 11374227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.